 Patrick Hume
Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cigarette Smoking | 2 | 2022 | 74 | 1.370 |
Why?
| | Lung | 7 | 2023 | 3561 | 0.830 |
Why?
| | Perfusion | 1 | 2021 | 148 | 0.700 |
Why?
| | Pressure | 1 | 2021 | 214 | 0.680 |
Why?
| | Pulmonary Emphysema | 1 | 2022 | 272 | 0.660 |
Why?
| | Blood Vessels | 1 | 2021 | 180 | 0.650 |
Why?
| | Polyethylene Glycols | 3 | 2012 | 561 | 0.610 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 373 | 0.600 |
Why?
| | Macrophages, Alveolar | 2 | 2022 | 348 | 0.600 |
Why?
| | Patient Care Planning | 1 | 2018 | 139 | 0.570 |
Why?
| | Hydrogels | 4 | 2023 | 573 | 0.570 |
Why?
| | Shock, Septic | 1 | 2018 | 186 | 0.530 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 916 | 0.480 |
Why?
| | Hospital Mortality | 1 | 2018 | 776 | 0.460 |
Why?
| | Coated Materials, Biocompatible | 1 | 2011 | 54 | 0.360 |
Why?
| | Metalloporphyrins | 1 | 2011 | 103 | 0.360 |
Why?
| | Biomimetic Materials | 1 | 2011 | 64 | 0.360 |
Why?
| | Superoxides | 1 | 2011 | 214 | 0.360 |
Why?
| | fas Receptor | 1 | 2010 | 91 | 0.340 |
Why?
| | Polymers | 2 | 2011 | 448 | 0.330 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 306 | 0.330 |
Why?
| | Photochemistry | 1 | 2010 | 125 | 0.330 |
Why?
| | Mice | 10 | 2023 | 14871 | 0.310 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1737 | 0.310 |
Why?
| | Dendritic Cells | 1 | 2012 | 435 | 0.310 |
Why?
| | Biocompatible Materials | 1 | 2012 | 369 | 0.300 |
Why?
| | Apoptosis | 2 | 2011 | 2363 | 0.230 |
Why?
| | Leukocytes | 2 | 2022 | 276 | 0.230 |
Why?
| | Animals | 10 | 2023 | 31708 | 0.220 |
Why?
| | X-Ray Microtomography | 1 | 2022 | 73 | 0.200 |
Why?
| | Vascular System Injuries | 1 | 2023 | 66 | 0.200 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2022 | 31 | 0.200 |
Why?
| | Precancerous Conditions | 1 | 2023 | 158 | 0.200 |
Why?
| | Vaping | 1 | 2023 | 45 | 0.200 |
Why?
| | Neuropeptides | 1 | 2022 | 65 | 0.190 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2023 | 71 | 0.190 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2022 | 49 | 0.190 |
Why?
| | Fixatives | 1 | 2021 | 15 | 0.190 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 249 | 0.180 |
Why?
| | Lung Injury | 1 | 2023 | 198 | 0.180 |
Why?
| | Leukosialin | 1 | 2020 | 15 | 0.180 |
Why?
| | Mannose-Binding Lectins | 1 | 2020 | 13 | 0.180 |
Why?
| | Optical Devices | 1 | 2020 | 13 | 0.180 |
Why?
| | Killer Cells, Natural | 1 | 2023 | 380 | 0.180 |
Why?
| | Lectins, C-Type | 1 | 2020 | 61 | 0.170 |
Why?
| | Medical Writing | 1 | 2019 | 2 | 0.170 |
Why?
| | Cell Count | 1 | 2020 | 303 | 0.170 |
Why?
| | Boston | 1 | 2018 | 75 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 687 | 0.150 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 355 | 0.150 |
Why?
| | Tissue Donors | 1 | 2020 | 316 | 0.150 |
Why?
| | Mice, Transgenic | 1 | 2022 | 1950 | 0.140 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 227 | 0.140 |
Why?
| | Linear Models | 1 | 2018 | 768 | 0.130 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1629 | 0.130 |
Why?
| | Macrophages | 1 | 2022 | 1263 | 0.120 |
Why?
| | Humans | 12 | 2023 | 114699 | 0.120 |
Why?
| | Disease Management | 1 | 2018 | 560 | 0.120 |
Why?
| | Research Design | 1 | 2019 | 928 | 0.110 |
Why?
| | Biomedical Research | 1 | 2019 | 585 | 0.110 |
Why?
| | Flow Cytometry | 2 | 2022 | 1083 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2020 | 3003 | 0.110 |
Why?
| | Mice, Inbred C57BL | 1 | 2022 | 4694 | 0.110 |
Why?
| | Disease Models, Animal | 1 | 2022 | 3535 | 0.110 |
Why?
| | Coculture Techniques | 1 | 2012 | 201 | 0.090 |
Why?
| | Glucose Oxidase | 1 | 2011 | 18 | 0.090 |
Why?
| | 3T3 Cells | 1 | 2011 | 140 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2177 | 0.090 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2012 | 153 | 0.090 |
Why?
| | Materials Testing | 1 | 2012 | 337 | 0.090 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 555 | 0.090 |
Why?
| | Jurkat Cells | 1 | 2010 | 128 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2012 | 299 | 0.090 |
Why?
| | Middle Aged | 2 | 2020 | 26738 | 0.080 |
Why?
| | Cell Adhesion | 1 | 2010 | 432 | 0.080 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1037 | 0.070 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 646 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 797 | 0.070 |
Why?
| | Genetic Enhancement | 1 | 2006 | 6 | 0.070 |
Why?
| | DNA Probes | 1 | 2006 | 59 | 0.070 |
Why?
| | Cell Line | 1 | 2011 | 2637 | 0.060 |
Why?
| | Protein Engineering | 1 | 2006 | 98 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2012 | 1701 | 0.060 |
Why?
| | Escherichia coli Proteins | 1 | 2006 | 162 | 0.060 |
Why?
| | Male | 2 | 2020 | 55606 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2006 | 740 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2011 | 3886 | 0.060 |
Why?
| | Urethane | 1 | 2023 | 41 | 0.060 |
Why?
| | Female | 2 | 2020 | 59520 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2023 | 143 | 0.050 |
Why?
| | Receptors, KIR | 1 | 2023 | 92 | 0.050 |
Why?
| | Ceramides | 1 | 2023 | 91 | 0.050 |
Why?
| | Escherichia coli | 1 | 2006 | 720 | 0.050 |
Why?
| | Thymus Gland | 1 | 2023 | 296 | 0.050 |
Why?
| | Aged | 1 | 2020 | 19074 | 0.050 |
Why?
| | Adolescent | 1 | 2020 | 17853 | 0.050 |
Why?
| | Tidal Volume | 1 | 2022 | 75 | 0.050 |
Why?
| | Positive-Pressure Respiration | 1 | 2022 | 68 | 0.050 |
Why?
| | Dronabinol | 1 | 2023 | 118 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 309 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 562 | 0.050 |
Why?
| | Time Factors | 1 | 2011 | 6116 | 0.050 |
Why?
| | Financing, Organized | 1 | 2019 | 33 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2022 | 590 | 0.040 |
Why?
| | Signal Transduction | 1 | 2012 | 4515 | 0.040 |
Why?
| | Adult | 1 | 2020 | 30553 | 0.040 |
Why?
| | Respiration, Artificial | 1 | 2022 | 529 | 0.040 |
Why?
| | Teaching | 1 | 2019 | 213 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2022 | 687 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 958 | 0.030 |
Why?
| | United States | 1 | 2023 | 12186 | 0.020 |
Why?
| | Heat-Shock Response | 1 | 2006 | 46 | 0.020 |
Why?
| | Drug Tolerance | 1 | 2006 | 79 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2006 | 345 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2006 | 311 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2006 | 1230 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2006 | 2765 | 0.010 |
Why?
| | Mutation | 1 | 2006 | 3346 | 0.010 |
Why?
|
|
Hume's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|